Clinical trial
Theophylline in Treating Cancer Patients With Shortness of Breath
NCT00003684 · NCIC Clinical Trials Group, Other · Completed
Key facts
| NCT number | NCT00003684 |
|---|---|
| Title | Theophylline in Treating Cancer Patients With Shortness of Breath |
| Official title | A Phase III Double-Blind Study of Theophylline Versus Placebo for the Treatment of Dyspnea in Cancer Patients |
| Lead sponsor | NCIC Clinical Trials Group, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Pulmonary Complications, Quality of Life, Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug, Procedure |
| Interventions | theophylline, quality-of-life assessment |
| Enrollment | 3 |
| Start date | Mar 24, 1998 |
| Primary completion | Dec 15, 2008 |
| Completion | Dec 15, 2008 |
| First posted | Aug 17, 2004 |
| Last update posted | Apr 3, 2020 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: